| G proteins control diverse pathways of transmembrane signaling1 M Freissmuth, PJ Casey, AG Gilman The FASEB journal 3 (10), 2125-2131, 1989 | 515 | 1989 |
| Laryngeal recurrent nerve injury in surgery for benign thyroid diseases: effect of nerve dissection and impact of individual surgeon in more than 27,000 nerves at risk M Hermann, G Alk, R Roka, K Glaser, M Freissmuth Annals of surgery 235 (2), 261, 2002 | 420 | 2002 |
| Adenosine receptors: G protein-mediated signalling and the role of accessory proteins M Klinger, M Freissmuth, C Nanoff Cellular signalling 14 (2), 99-108, 2002 | 310 | 2002 |
| Neuromonitoring in thyroid surgery: prospective evaluation of intraoperative electrophysiological responses for the prediction of recurrent laryngeal nerve injury M Hermann, C Hellebart, M Freissmuth Annals of surgery 240 (1), 9, 2004 | 293 | 2004 |
| Expression of Gsα in Escherichia coli: purification and properties of two forms of the protein MP Graziano, M Freissmuth, AG Gilman Journal of Biological Chemistry 264 (1), 409-418, 1989 | 283 | 1989 |
| Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells JA Schmid, P Scholze, O Kudlacek, M Freissmuth, EA Singer, HH Sitte Journal of Biological Chemistry 276 (6), 3805-3810, 2001 | 226 | 2001 |
| Mutations of GS α designed to alter the reactivity of the protein with bacterial toxins: substitutions at ARG187 result in loss of GTPase activity M Freissmuth, AG Gilman Journal of Biological Chemistry 264 (36), 21907-21914, 1989 | 223 | 1989 |
| A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis K Kollmann, G Heller, C Schneckenleithner, W Warsch, R Scheicher, ... Cancer cell 24 (2), 167-181, 2013 | 215 | 2013 |
| Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells V Sexl, G Mancusi, C Höller, E Gloria-Maercker, W Schütz, M Freissmuth Journal of Biological Chemistry 272 (9), 5792-5799, 1997 | 211 | 1997 |
| Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling V O'Connor, O El Far, E Bofill-Cardona, C Nanoff, M Freissmuth, ... Science 286 (5442), 1180-1184, 1999 | 178 | 1999 |
| Reverse intrinsic activity of antagonists on G protein-coupled receptors W Schütz, M Freissmuth Trends in pharmacological sciences 13, 376-380, 1992 | 177 | 1992 |
| Suramin analogues as subtype-selective G protein inhibitors. M Freissmuth, S Boehm, W Beindl, P Nickel, AP Ijzerman, M Hohenegger, ... Molecular pharmacology 49 (4), 602-611, 1996 | 171 | 1996 |
| Risk factors for postoperative bleeding after thyroid surgery R Promberger, J Ott, F Kober, C Koppitsch, R Seemann, M Freissmuth, ... British Journal of Surgery 99 (3), 373-379, 2012 | 170 | 2012 |
| Amphetamines, new psychoactive drugs and the monoamine transporter cycle HH Sitte, M Freissmuth Trends in pharmacological sciences 36 (1), 41-50, 2015 | 169 | 2015 |
| Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. B Bertin, M Freissmuth, RM Breyer, W Schütz, AD Strosberg, S Marullo Journal of Biological Chemistry 267 (12), 8200-8206, 1992 | 162 | 1992 |
| Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. HE Melikian, S Ramamoorthy, CG Tate, RD Blakely Molecular Pharmacology 50 (2), 266-276, 1996 | 161 | 1996 |
| Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21ras-dependent Pathway MG Seidel, M Klinger, M Freissmuth, C Höller Journal of Biological Chemistry 274 (36), 25833-25841, 1999 | 149 | 1999 |
| Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch E Bofill-Cardona, O Kudlacek, Q Yang, H Ahorn, M Freissmuth, C Nanoff Journal of Biological Chemistry 275 (42), 32672-32680, 2000 | 147 | 2000 |
| STAT1 acts as a tumor promoter for leukemia development B Kovacic, D Stoiber, R Moriggl, E Weisz, RG Ott, R Kreibich, DE Levy, ... Cancer cell 10 (1), 77-87, 2006 | 146 | 2006 |
| Inhibition of receptor/G protein coupling by suramin analogues. W Beindl, T Mitterauer, M Hohenegger, AP Ijzerman, C Nanoff, ... Molecular Pharmacology 50 (2), 415-423, 1996 | 145 | 1996 |
